These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 30835794)
1. FDA-Approved Drugs to Treat ADHD. J Psychosoc Nurs Ment Health Serv; 2019 Mar; 57(3):5-6. PubMed ID: 30835794 [No Abstract] [Full Text] [Related]
2. FDA-Approved Drugs to Treat ADHD. J Psychosoc Nurs Ment Health Serv; 2018 Mar; 56(3):13-14. PubMed ID: 29505085 [No Abstract] [Full Text] [Related]
3. FDA-Approved Drugs to Treat ADHD. J Psychosoc Nurs Ment Health Serv; 2017 Mar; 55(3):17-18. PubMed ID: 28287670 [No Abstract] [Full Text] [Related]
4. FDA-Approved Drugs to Treat ADHD. J Psychosoc Nurs Ment Health Serv; 2020 Mar; 58(3):5-6. PubMed ID: 32129874 [No Abstract] [Full Text] [Related]
5. FDA-approved drugs to treat ADHD. J Psychosoc Nurs Ment Health Serv; 2012 Mar; 50(3):11-2. PubMed ID: 22390784 [No Abstract] [Full Text] [Related]
6. Clip & save: drug chart. FDA-approved drugs to treat ADHD. J Psychosoc Nurs Ment Health Serv; 2010 Mar; 48(3):9-10. PubMed ID: 20302260 [No Abstract] [Full Text] [Related]
7. FDA-Approved Drugs to Treat ADHD. J Psychosoc Nurs Ment Health Serv; 2021 Mar; 59(3):3-4. PubMed ID: 33647155 [No Abstract] [Full Text] [Related]
8. FDA-Approved Drugs to Treat ADHD. J Psychosoc Nurs Ment Health Serv; 2022 Mar; 60(3):5-6. PubMed ID: 35244493 [No Abstract] [Full Text] [Related]
9. FDA-approved drugs to treat ADHD. J Psychosoc Nurs Ment Health Serv; 2014 Mar; 52(3):9-10. PubMed ID: 24598177 [No Abstract] [Full Text] [Related]
10. FDA ponders cardiovascular risks of ADHD drugs. Young D Am J Health Syst Pharm; 2006 Mar; 63(6):492-4. PubMed ID: 16522874 [No Abstract] [Full Text] [Related]
11. A new amphetamine oral suspension (Adzenys ER) for ADHD. Med Lett Drugs Ther; 2018 Jun; 60(1549):e106-e108. PubMed ID: 29913476 [No Abstract] [Full Text] [Related]
12. Premarket safety and efficacy studies for ADHD medications in children. Bourgeois FT; Kim JM; Mandl KD PLoS One; 2014; 9(7):e102249. PubMed ID: 25007171 [TBL] [Abstract][Full Text] [Related]
13. FDA-approved drugs to treat ADHD. J Psychosoc Nurs Ment Health Serv; 2013 Mar; 51(3):11-2. PubMed ID: 23452016 [No Abstract] [Full Text] [Related]
14. Quillivant XR--an extended release oral suspension of methylphenidate. Med Lett Drugs Ther; 2013 Feb; 55(1409):10-1. PubMed ID: 23381227 [No Abstract] [Full Text] [Related]
15. [Attention deficit-hyperactivity disorder (ADHD); etiology, diagnosis and treatment]. 't Jong GW; van den Anker JN Ned Tijdschr Geneeskd; 2000 Nov; 144(46):2227-8. PubMed ID: 11103263 [No Abstract] [Full Text] [Related]
17. The latest drugs on the FDA's radar. Waldron T Behav Healthc; 2006 Jun; 26(6):34-5. PubMed ID: 16833213 [No Abstract] [Full Text] [Related]
18. With the recent Food and Drug Administration (FDA) Advisory Committee's recommendation to put a black box warning on stimulants, the government has joined the media in raising alarm about the medical treatment of attention-deficit disorder. Hackford R J Dev Behav Pediatr; 2006 Apr; 27(2):179. PubMed ID: 16682886 [No Abstract] [Full Text] [Related]
19. Compliance with FDA recommendations for pemoline. Sarkis EH J Am Acad Child Adolesc Psychiatry; 2003 Apr; 42(4):383; author reply 383. PubMed ID: 12649623 [No Abstract] [Full Text] [Related]
20. Drug development process for a product with a primary pediatric indication. Allen AJ; Michelson D J Clin Psychiatry; 2002; 63 Suppl 12():44-9. PubMed ID: 12562061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]